Zobrazeno 1 - 10
of 482
pro vyhledávání: '"Stephen G Worthley"'
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 2 (2008)
Externí odkaz:
https://doaj.org/article/4fc9e6106c70481db06759a772556ae7
Autor:
Michael J. Reardon, Bassem Chehab, Dave Smith, Antony S. Walton, Stephen G. Worthley, Ganesh Manoharan, Ibrahim Sultan, Gerald Yong, Katherine Harrington, Paul Mahoney, Neal Kleiman, Raj R. Makkar, Gregory Fontana, Augustin DeLago, Ravi K. Ramana, Nicholas Bates, Lars Søndergaard
Publikováno v:
JACC: Cardiovascular Interventions. 16:681-689
Autor:
Anthony C. Camuglia, Christopher M.W. Cole, Nicholas Boyne, Sam M. Hayman, Stephen V. Cox, Peter T. Moore, Jerrett K. Lau, Sinny Delacroix, Anna Emilie Williamson, MyNgan Duong, Nisha Schwarz, Joseph K. Montarello, Stephen G. Worthley
Publikováno v:
Heart, Lung and Circulation. 32:224-231
Transcatheter aortic valve implantation (TAVI) is an established therapy for the treatment of aortic valve disease in appropriately selected patients. Previous studies using the self-expanding Portico transcatheter heart valve (THV), (Abbott Structur
Autor:
Stephan Windecker, Azeem Latib, Elvin Kedhi, Ajay J. Kirtane, David E. Kandzari, Roxana Mehran, Matthew J. Price, Alexandre Abizaid, Daniel I. Simon, Stephen G. Worthley, Azfar Zaman, Martin Hudec, Petra Poliacikova, Abdul Kahar bin Abdul Ghapar, Kamaraj Selvaraj, Ivo Petrov, Darren Mylotte, Eduardo Pinar, Raul Moreno, Franco Fabbiocchi, Sanjeevan Pasupati, Hyo-Soo Kim, Adel Aminian, Charles Tie, Adrian Wlodarczak, Seung-Ho Hur, Steven O. Marx, Ziad A. Ali, Maria Parke, Te-Hsin Lung, Gregg W. Stone
Publikováno v:
JACC: Cardiovascular Interventions. 15:1153-1163
Autor:
Stephen G. Worthley, John Gregson, David Hildick-Smith, Andrejs Erglis, Alan Whelan, Mark Horrigan, Sinny Delacroix, Tony Rafter, Federico De Marco, Simon Redwood
Publikováno v:
EuroIntervention
AIMS: The aim of this study was to assess the one-year safety and efficacy of the transcatheter ARTO system in the treatment of functional mitral regurgitation (FMR). METHODS AND RESULTS: MAVERIC is a multicentre, prospective, non-randomised pre-comm
Autor:
Bassem M. Chehab, David Smith, Federico M. Asch, Gerald Yong, Paul Mahoney, Gregory P. Fontana, Gaurav Dhar, Raj Makkar, Ravi K. Ramana, Mark Groh, Tarun Chakravarty, Antony Walton, Stephen G. Worthley, Hasan Jilaihawi, H. Edward Garrett, Ganesh Manoharan, Francesco Bedogni, James B. Hermiller, Ron Waksman
Publikováno v:
JACC: Cardiovascular Interventions. 13:2467-2478
The aim of this study was to characterize the safety profile of an intra-annular self-expanding valve with a next-generation low-profile delivery system (DS).Key design modifications to the FlexNav DS include the addition of a hydrophilic-coated, int
Autor:
William Abernethy, Mark J. Cunningham, James B. Hermiller, Ravi K. Ramana, Carlos E. Ruiz, Ron Waksman, Stephen G. Worthley, Samir R. Kapadia, Ray V. Matthews, Michael J. Reardon, Gerald Yong, Mark Groh, Rahul Sharma, Lowell F. Satler, David Heimansohn, Wen Cheng, Mamoo Nakamura, Sung Han Yoon, Bassem M. Chehab, Gregory P. Fontana, Hasan Jilaihawi, Mark J. Russo, Chunguang Chen, Tarun Chakravarty, Deepak L. Bhatt, Federico M. Asch, Raj Makkar, Augusto D. Pichard
Publikováno v:
The Lancet. 396:669-683
Summary Background Randomised trial data assessing the safety and efficacy of the self-expanding intra-annular Portico transcatheter aortic valve system (Abbott Structural Heart, St Paul, MN, USA) compared with any commercially available valves are n
Autor:
Natalie Montarello, Joseph Montarello, Adam J. Nelson, Ross L. Roberts-Thomson, Nicholas J. Montarello, Stephen G. Worthley
Publikováno v:
IHJ Cardiovascular Case Reports (CVCR). 4:17-20
Technical advancements together with robust clinical trial evidence continue to extend the reach of transcatheter therapies. Conditions once considered amenable only to surgery, are now treatable percutaneously offering not only safe outcomes, but in
Autor:
David Eccleston, My-Ngan Duong, Enayet Chowdhury, Nisha Schwarz, Christopher Reid, Danny Liew, Andre Conradie, Stephen G. Worthley
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 4
Pages: 1684
Volume 12
Issue 4
Pages: 1684
Background: Readmissions within 1 year after percutaneous coronary intervention (PCI) are common (18.6–50.4% in international series) and a burden to patients and health services, however their long-term implications are not well characterised. We
Autor:
David S. Eccleston, Enayet Chowdhury, Tony Rafter, Peter Sage, Alan Whelan, Christopher Reid, Danny Liew, MyNgan Duong, Nisha Schwarz, Stephen G. Worthley
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 280
Introduction: Several large registries have evaluated outcomes after percutaneous coronary intervention (PCI) in the USA, however there are no contemporary data regarding long-term outcomes after PCI, particularly comparing new generation drug-elutin